{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T01:36:18Z","timestamp":1769823378268,"version":"3.49.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T00:00:00Z","timestamp":1707264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T00:00:00Z","timestamp":1707264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["831514"],"award-info":[{"award-number":["831514"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI Phys"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>PET scans using zirconium-89 labelled monoclonal antibodies (<jats:sup>89<\/jats:sup>Zr-mAbs), known as <jats:sup>89<\/jats:sup>Zr-immuno-PET, are made to measure uptake in tumour and organ tissue. Uptake is related to the supply of <jats:sup>89<\/jats:sup>Zr-mAbs in the blood. Measuring activity concentrations in blood, however, requires invasive blood sampling. This study aims to identify the best delineation strategy to obtain the image-derived blood concentration (IDBC) from <jats:sup>89<\/jats:sup>Zr-immuno-PET scans.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>PET imaging and blood sampling of two <jats:sup>89<\/jats:sup>Zr-mAbs were included, <jats:sup>89<\/jats:sup>Zr-cetuximab and <jats:sup>89<\/jats:sup>Zr-durvalumab. For seven patients receiving <jats:sup>89<\/jats:sup>Zr-cetuximab, PET scans on 1\u20132\u00a0h, 2 and 6\u00a0days post-injection (p.i.) were analysed. Five patients received three injections of <jats:sup>89<\/jats:sup>Zr-durvalumab. The scanning protocol for the first two injections consisted of PET scanning on 2, 5 and 7\u00a0days p.i. and for the third injection only on 7\u00a0days p.i. Blood samples were drawn with every PET scan and the sample-derived blood concentration (SDBC) was used as gold standard for the IDBC. According to an in-house developed standard operating procedure, the aortic arch, ascending aorta, descending aorta and left ventricle were delineated. Bland\u2013Altman analyses were performed to assess the bias (mean difference) and variability (1.96 times the standard deviation of the differences) between IDBC and SDBC.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Overall, the activity concentration obtained from the IDBC was lower than from the SDBC. When comparing IDBC with SDBC, variability was smallest for the ascending aorta (20.3% and 17.0% for <jats:sup>89<\/jats:sup>Zr-cetuximab and <jats:sup>89<\/jats:sup>Zr-durvalumab, respectively). Variability for the other regions ranged between 17.9 and 30.8%. Bias for the ascending aorta was\u2009\u2212\u200910.9% and\u2009\u2212\u200911.4% for <jats:sup>89<\/jats:sup>Zr-cetuximab and <jats:sup>89<\/jats:sup>Zr-durvalumab, respectively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Image-derived blood concentrations should be obtained from delineating the ascending aorta in <jats:sup>89<\/jats:sup>Zr-immuno-PET scans, as this results in the lowest variability with respect to sample-derived blood concentrations.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40658-024-00621-7","type":"journal-article","created":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T04:41:48Z","timestamp":1707280908000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["How to obtain the image-derived blood concentration from 89Zr-immuno-PET scans"],"prefix":"10.1186","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1486-6246","authenticated-orcid":false,"given":"Jessica E.","family":"Wijngaarden","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amina","family":"Ahbari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna E. E.","family":"Pouw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henri N. J. M.","family":"Greuter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Idris","family":"Bahce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerben J. C.","family":"Zwezerijnen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dani\u00eblle J.","family":"Vugts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guus A. M. S.","family":"van Dongen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald","family":"Boellaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. Willemien","family":"Menke-van der Houven van Oordt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc C.","family":"Huisman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,2,7]]},"reference":[{"issue":"4","key":"621_CR1","doi-asserted-by":"publisher","first-page":"438","DOI":"10.2967\/jnumed.119.239558","volume":"62","author":"GAMS van Dongen","year":"2021","unstructured":"van Dongen GAMS, Beaino W, Windhorst AD, Zwezerijnen GJC, Oprea-Lager DE, Hendrikse NH, van Kuijk C, Boellaard R, Huisman MC, Vugts DJ. The role of 89Zr-immuno-PET in navigating and derisking the development of biopharmaceuticals. J Nucl Med. 2021;62(4):438\u201345. https:\/\/doi.org\/10.2967\/jnumed.119.239558.","journal-title":"J Nucl Med"},{"issue":"Suppl 1","key":"621_CR2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s00259-006-0131-5","volume":"33","author":"AA Lammertsma","year":"2006","unstructured":"Lammertsma AA, Hoekstra CJ, Giaccone G, Hoekstra OS. How should we analyse FDG PET studies for monitoring tumour response? Eur J Nucl Med Mol Imaging. 2006;33(Suppl 1):16\u201321. https:\/\/doi.org\/10.1007\/s00259-006-0131-5.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"621_CR3","doi-asserted-by":"publisher","unstructured":"Miedema IHC, Huisman MC, Zwezerijnen GJC, Grempler R, Pitarch AP, Thiele A, Hesse R, Elgadi M, Peltzer A, Vugts DJ, van Dongen GAMS, de Gruijl TD, Menke-van der Houven van Oordt CW, Bahce I. 89Zr-immuno-PET using the anti-LAG-3 tracer [89Zr]Zr-BI 754111: demonstrating target specific binding in NSCLC and HNSCC. Eur J Nucl Med Mol Imaging. 2023;50(7):2068\u201380. https:\/\/doi.org\/10.1007\/s00259-023-06164-w.","DOI":"10.1007\/s00259-023-06164-w"},{"key":"621_CR4","doi-asserted-by":"publisher","unstructured":"Wijngaarden JE, Huisman MC, Jauw YWS, van Dongen GAMS, Greuter HNJM, Schuit RC, Cleveland M, Gootjes EC, Vugts DJ, Menke-van der Houven van Oordt CW, Boellaard R. Validation of simplified uptake measures against dynamic Patlak Ki for quantification of lesional 89Zr-Immuno-PET antibody uptake. Eur J Nucl Med Mol Imaging. 2023;50(7):1897\u2013905. https:\/\/doi.org\/10.1007\/s00259-023-06151-1.","DOI":"10.1007\/s00259-023-06151-1"},{"issue":"1","key":"621_CR5","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/2191-219X-4-18","volume":"4","author":"J van den Hoff","year":"2014","unstructured":"van den Hoff J, Lougovski A, Schramm G, Maus J, Oehme L, Petr J, Beuthien-Baumann B, Kotzerke J, Hofheinz F. Correction of scan time dependence of standard uptake values in oncological PET. EJNMMI Res. 2014;4(1):18. https:\/\/doi.org\/10.1186\/2191-219X-4-18.","journal-title":"EJNMMI Res"},{"issue":"3","key":"621_CR6","first-page":"359","volume":"30","author":"SS Gambhir","year":"1989","unstructured":"Gambhir SS, Schwaiger M, Huang SC, Krivokapich J, Schelbert HR, Nienaber CA, Phelps ME. Simple noninvasive quantification method for measuring myocardial glucose utilization in humans employing positron emission tomography and fluorine-18 deoxyglucose. J Nucl Med. 1989;30(3):359\u201366.","journal-title":"J Nucl Med"},{"issue":"6","key":"621_CR7","first-page":"945","volume":"47","author":"LF de Geus-Oei","year":"2006","unstructured":"de Geus-Oei LF, Visser EP, Krabbe PF, van Hoorn BA, Koenders EB, Willemsen AT, Pruim J, Corstens FH, Oyen WJ. Comparison of image-derived and arterial input functions for estimating the rate of glucose metabolism in therapy-monitoring 18F-FDG PET studies. J Nucl Med. 2006;47(6):945\u20139.","journal-title":"J Nucl Med"},{"issue":"11","key":"621_CR8","first-page":"1622","volume":"42","author":"AP van der Weerdt","year":"2001","unstructured":"van der Weerdt AP, Klein LJ, Boellaard R, Visser CA, Visser FC, Lammertsma AA. Image-derived input functions for determination of MRGlu in cardiac (18)F-FDG PET scans. J Nucl Med. 2001;42(11):1622\u20139.","journal-title":"J Nucl Med"},{"issue":"3","key":"621_CR9","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s00259-008-0986-8","volume":"36","author":"JE Mourik","year":"2009","unstructured":"Mourik JE, Lubberink M, Schuitemaker A, Tolboom N, van Berckel BN, Lammertsma AA, Boellaard R. Image-derived input functions for PET brain studies. Eur J Nucl Med Mol Imaging. 2009;36(3):463\u201371. https:\/\/doi.org\/10.1007\/s00259-008-0986-8.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"8","key":"621_CR10","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.2967\/jnumed.115.156711","volume":"56","author":"AT Soderlund","year":"2015","unstructured":"Soderlund AT, Chaal J, Tjio G, Totman JJ, Conti M, Townsend DW. Beyond 18F-FDG: characterization of PET\/CT and PET\/MR scanners for a comprehensive set of positron emitters of growing application\u201318F, 11C, 89Zr, 124I, 68Ga, and 90Y. J Nucl Med. 2015;56(8):1285\u201391. https:\/\/doi.org\/10.2967\/jnumed.115.156711.","journal-title":"J Nucl Med"},{"issue":"6","key":"621_CR11","doi-asserted-by":"publisher","first-page":"932","DOI":"10.2967\/jnumed.106.035774","volume":"48","author":"M Soret","year":"2007","unstructured":"Soret M, Bacharach SL, Buvat I. Partial-volume effect in PET tumor imaging. J Nucl Med. 2007;48(6):932\u201345. https:\/\/doi.org\/10.2967\/jnumed.106.035774.","journal-title":"J Nucl Med"},{"issue":"11","key":"621_CR12","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.2967\/jnumed.109.065862","volume":"50","author":"PK B\u00f6rjesson","year":"2009","unstructured":"B\u00f6rjesson PK, Jauw YW, de Bree R, Roos JC, Castelijns JA, Leemans CR, van Dongen GA, Boellaard R. Radiation dosimetry of 89Zr-labeled chimeric monoclonal antibody U36 as used for immuno-PET in head and neck cancer patients. J Nucl Med. 2009;50(11):1828\u201336. https:\/\/doi.org\/10.2967\/jnumed.109.065862.","journal-title":"J Nucl Med"},{"key":"621_CR13","doi-asserted-by":"publisher","unstructured":"Jauw YWS, Heijtel DF, Zijlstra JM, Hoekstra OS, de Vet HCW, Vugts DJ, Verheul HM, Boellaard R, Zweegman S, van Dongen GAMS, der Houven van Oordt CWM, Lammertsma AA, Huisman MC. Noise-induced variability of immuno-PET with zirconium-89-labeled antibodies: an analysis based on count-reduced clinical images. Mol Imaging Biol. 2018;20(6):1025\u201334. https:\/\/doi.org\/10.1007\/s11307-018-1200-4.","DOI":"10.1007\/s11307-018-1200-4"},{"issue":"8476","key":"621_CR14","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","volume":"1","author":"JM Bland","year":"1986","unstructured":"Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1(8476):307\u201310.","journal-title":"Lancet"},{"issue":"3","key":"621_CR15","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/s00259-017-3853-7","volume":"45","author":"A Kaalep","year":"2018","unstructured":"Kaalep A, Sera T, Oyen W, Krause BJ, Chiti A, Liu Y, Boellaard R. EANM\/EARL FDG-PET\/CT accreditation\u2014summary results from the first 200 accredited imaging systems. Eur J Nucl Med Mol Imaging. 2018;45(3):412\u201322. https:\/\/doi.org\/10.1007\/s00259-017-3853-7.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"20","key":"621_CR16","doi-asserted-by":"publisher","first-page":"4887","DOI":"10.1088\/0031-9155\/50\/20\/010","volume":"50","author":"A Rahmim","year":"2005","unstructured":"Rahmim A, Cheng JC, Blinder S, Camborde ML, Sossi V. Statistical dynamic image reconstruction in state-of-the-art high-resolution PET. Phys Med Biol. 2005;50(20):4887\u2013912. https:\/\/doi.org\/10.1088\/0031-9155\/50\/20\/010.","journal-title":"Phys Med Biol"},{"issue":"7","key":"621_CR17","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1093\/annonc\/mdp549","volume":"21","author":"J Tabernero","year":"2010","unstructured":"Tabernero J, Ciardiello F, Rivera F, Rodrigeuz-Braun E, Ramos FJ, Martinelli E, Vega-Villegas ME, Rosell\u00f3 S, Liebscher S, Kisker O, Macarulla T, Baselga J, Cervantes A. Cetuximab administered once every second week to patients with metastatic colorectal cancer: a two-part pharmacokinetic\/pharmacodynamics phase I dose-escalation study. Ann Oncol. 2010;21(7):1537\u201345. https:\/\/doi.org\/10.1093\/annonc\/mdp549.","journal-title":"Ann Oncol"},{"issue":"9","key":"621_CR18","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1080\/14712598.2019.1635115","volume":"19","author":"J Alvarez-Argote","year":"2019","unstructured":"Alvarez-Argote J, Dasanu CA. Durvalumab in cancer medicine: a comprehensive review. Expert Opin Biol Ther. 2019;19(9):927\u201335. https:\/\/doi.org\/10.1080\/14712598.2019.1635115.","journal-title":"Expert Opin Biol Ther"},{"key":"621_CR19","doi-asserted-by":"publisher","unstructured":"Hindorf C, Glatting G, Chiesa C, Lind\u00e9n O, Flux G;,EANM Dosimetry Committee. EANM Dosimetry Committee guidelines for bone marrow and whole-body dosimetry. Eur J Nucl Med Mol Imaging. 2010;37(6):1238\u201350. https:\/\/doi.org\/10.1007\/s00259-010-1422-4.","DOI":"10.1007\/s00259-010-1422-4"},{"issue":"2","key":"621_CR20","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2967\/jnumed.114.147819","volume":"56","author":"NE Makris","year":"2015","unstructured":"Makris NE, Boellaard R, van Lingen A, Lammertsma AA, van Dongen GA, Verheul HM, Menke CW, Huisman MC. PET\/CT-derived whole-body and bone marrow dosimetry of 89Zr-cetuximab. J Nucl Med. 2015;56(2):249\u201354. https:\/\/doi.org\/10.2967\/jnumed.114.147819.","journal-title":"J Nucl Med"},{"key":"621_CR21","doi-asserted-by":"publisher","unstructured":"Frings V, Yaqub M, Hoyng LL, Golla SS, Windhorst AD, Schuit RC, Lammertsma AA, Hoekstra OS, Smit EF, Boellaard R, QuIC-ConCePT Consortium. Assessment of simplified methods to measure 18F-FLT uptake changes in EGFR-mutated non-small cell lung cancer patients undergoing EGFR tyrosine kinase inhibitor treatment. J Nucl Med. 2014;55(9):1417\u201323. https:\/\/doi.org\/10.2967\/jnumed.114.140913.","DOI":"10.2967\/jnumed.114.140913"},{"issue":"8","key":"621_CR22","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1007\/s00259-023-06194-4","volume":"50","author":"J van Sluis","year":"2023","unstructured":"van Sluis J, Boellaard R, Dierckx RAJO, van Esch ELM, Croes DA, de Ruijter LK, van de Donk PP, de Vries EGE, Noordzij W, Brouwers AH. Optimisation of scan duration and image quality in oncological 89Zr immunoPET imaging using the Biograph Vision PET\/CT. Eur J Nucl Med Mol Imaging. 2023;50(8):2258\u201370. https:\/\/doi.org\/10.1007\/s00259-023-06194-4.","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["EJNMMI Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40658-024-00621-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40658-024-00621-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40658-024-00621-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T04:46:20Z","timestamp":1707281180000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejnmmiphys.springeropen.com\/articles\/10.1186\/s40658-024-00621-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,7]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["621"],"URL":"https:\/\/doi.org\/10.1186\/s40658-024-00621-7","relation":{},"ISSN":["2197-7364"],"issn-type":[{"value":"2197-7364","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,7]]},"assertion":[{"value":"3 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16"}}